Issued Patents 2020
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10836999 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-11-17 |
| 10829737 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-11-10 |
| 10801012 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-10-13 |
| 10774309 | Natural killer cell immunotherapy for treating cancer | Yu-Hsiang Chang | 2020-09-15 |
| 10774311 | Natural killer cells modified to express membrane-bound interleukin 15 and uses thereof | David Shook, Masaru Imamura | 2020-09-15 |
| 10765699 | Methods for enhancing efficacy of therapeutic immune cells | Takahiro Kamiya | 2020-09-08 |
| 10647997 | Modified effector cell (or chimeric receptor) for treating disialoganglioside GD2-expressing neoplasia | Massimo Dominici, Sara Caldrer, Maria Carlotta Spano, Paolo Paolucci, Marco Bestagno | 2020-05-12 |
| 10550183 | Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies | Yi Tian Png, Natasha Vinanica, Takahiro Kamiya | 2020-02-04 |
| 10538739 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-01-21 |